Results for amyotrophic translation from French to English

amyotrophic lateral sclerosis:
the x-linked inhibitor of apoptosis (xiap):

treatment of amyotrophic lateral sclerosis
• treatment of amyotrophic lateral sclerosis

peripherin abnormalities in amyotrophic lateral sclerosis
biomechanics of balance and falls in the elderly

pathogenesis and therapy of amyotrophic latéral sclerosis.
neurol., 124, 73-88, 1993.

pathogenesi.s and therapy of amyotrophic latéral sclerosis.
pathogenesis and therapy of amyotrophic lateral sclerosis.

the role of inflammation in pathogenesis of amyotrophic lateral sclerosis
cck-b receptor polymorphism and vulnerability to cck-4-induced panic attacks in healthy subjects

• amyotrophic lateral sclerosis society of canada (rcmg)
• amyotrophic lateral sclerosis society of canada (cgdn)

kong, jiming university of manitoba amyotrophic lateral sclerosis:
korneluk, robert g children's hospital of eastern ontario (ottawa) the x-linked inhibitor of apoptosis (xiap):

characterization of a mouse model for juvenile amyotrophic lateral sclerosis
the role of inflammation in pathogenesis of amyotrophic lateral sclerosis

interplay of oxidative stress and protein misfolding in amyotrophic lateral sclerosis
context-dependent changes in neural processing in primary motor cortex

live imaging and analysis of disease onset and progression in amyotrophic lateral sclerosis
enhancing the response to rehabilitative interventions after stroke using transcranial magnetic stimulation

role of misfolded sod1 in the mitochondrial dysfunction of motor neuron cells resulting in amyotrophic lateral sclerosis
* "research institution" is displayed only when it is different from "institution paid".

elucidation of the cu, zn superoxide dismutase misfolding process: implications for understanding amyotrophic lateral sclerosis
* "research institution" is displayed only when it is different from "institution paid".

aluminum-induced neurodegeneration with special reference to amyotrophic lateral sclerosis and dialysis encephalopathy, rev. biochem.
aluminum-induced neurodegeneration with special reference to amyotrophic lateral sclerosis and dialysis encephalopathy.

fmc amyotrophic lateral sclerosis update for family physicians christen l. shoesmith, md, frcpcmichael j. strong, md, frcpc
cme amyotrophic lateral sclerosis update for family physicians christen l. shoesmith, md, frcpcmichael j. strong, md, frcpc

amyotrophic lateral sclerosis and parkinsonian syndromes in high incidence among the auyu and jakai people of west new guinea, neurology, 32: 107126.
amyotrophic lateral sclerosis and parkinsonian syndromes in high incidence among the auyu and jakai people of west new guinea.

gajdusek, d.c. et salazar, a. amyotrophic lateral sclerosis and parkinsonian syndromes in high incidence among the auya and jakai people of west new guinea.
gajdusek, d.c. and salazar, a. amyotrophic lateral sclerosis and parkinsonian syndromes in high incidence among the auya and jakai people of west new guinea.

cpmp/ewp/280/96cpmp/ewp/436/97 cpmp/ewp/1401/98 (incollaboration with qwp)points à considérer c linical investigation of medicinal products for the treatment of unstable coronary artery disease c linical investigation of medicinal products for prophylactic the treatment of peri-and post-operative venous thrombo-embolic risk c linical investigation of medicinal products for the treatment of venous thrombo-embolic d isease c linical investigation of medicinal products for prevention and the treatment of osteoporosis in men c linical investigation of medicinal products for the treatment of amyotrophic lateral sclerosis the evaluation of diagnostic agents
clinical investigation of medicinal products for prophylactic treatment of peri-and post-operative venous thrombo-embolic risk clinical investigation of medicinal products for treatment of venous thrombo-embolic disease clinical investigation of medicinal products for prevention and treatment of osteoporosis in men clinical investigation of medicinal products for treatment of amyotrophic lateral sclerosis the evaluation of diagnostic agents